Restricted Mean Survival Time: An Obligatory End Point for Time-to-Event Analysis in Cancer Trials?

Subjects

Subjects :

Disease Progression
Disease-Free Survival
Humans
Neoplasms epidemiology
Neoplasms mortality
Risk Factors
Time Factors
Treatment Outcome
Clinical Trials as Topic methods
Endpoint Determination
Medical Oncology methods
Neoplasms therapy

Details

Language :

English

ISSN :

1527-7755

Volume :

34

Issue :

28

Database :

MEDLINE

Journal :

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publication Type :

Editorial & Opinion

Accession number :

27507871

Full Text :

https://doi.org/10.1200/JCO.2016.67.8045